Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells
about
Control of human papillomavirus gene expression by alternative splicingMultiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.Study of infectious virus production from HPV18/16 capsid chimeras.The role of the globular heads of the C1q receptor in HPV-16 E2-induced human cervical squamous carcinoma cell apoptosis via a mitochondria-dependent pathwayDifferential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variationsThe landscape of alternative splicing in cervical squamous cell carcinoma.Assessing the detection of human papillomavirus late mRNA in liquid base cytology samples for risk stratification of cervical disease.Control of the papillomavirus early-to-late switch by differentially expressed SRp20Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.Characterization of novel transcripts of human papillomavirus type 16 using cap analysis gene expression technology.Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).HPV16 and 18 genome amplification show different E4-dependence, with 16E4 enhancing E1 nuclear accumulation and replicative efficiency via its cell cycle arrest and kinase activation functions.Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapiesHuman papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiationHuman papillomavirus molecular biology and disease association.RNA splicing factors regulated by HPV16 during cervical tumour progression.The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells.Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.Human papillomavirus gene expression is controlled by host cell splicing factors.A functional interaction between the MAGUK protein hDlg and the gap junction protein connexin 43 in cervical tumour cells.Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.Polypyrimidine tract binding protein induces human papillomavirus type 16 late gene expression by interfering with splicing inhibitory elements at the major late 5' splice site, SD3632Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation.The alternative splicing factor hnRNP A1 is up-regulated during virus-infected epithelial cell differentiation and binds the human papillomavirus type 16 late regulatory element.The Therapeutic Potential of CRISPR/Cas9 Systems in Oncogene-Addicted Cancer Types: Virally Driven Cancers as a Model System.Characterization of the Human Papillomavirus 16 E8 Promoter.RNASeq analysis of differentiated keratinocytes reveals a massive response to late events during human papillomavirus type 16 infection, including loss of epithelial barrier function.Mutations in HPV18 E1^E4 Impact Virus Capsid Assembly, Infectivity Competence, and Maturation.
P2860
Q28073341-36EEBC2E-E09C-457F-AA95-1984A8029ABFQ33592653-D621D925-9D45-47B6-8C38-C1E375AF0D36Q34071813-101F94F3-75FD-4809-945A-6AF5492245D8Q34325733-1A0C44A6-21F6-49D7-BFCC-CD7D3AB2E152Q34770066-EA75EBDE-E09D-4A2A-A10D-8566E0E0963BQ34783624-D494DB3F-65A7-4B4E-AE73-CC37E5163323Q34806026-B5EEE99F-8D59-4D87-AE49-E388739DA09EQ34863597-A14147ED-F8FB-4ED7-9F87-F3AC3AF4D1FCQ34988558-9A1CCD47-DE45-421B-86F6-8A64F9DA72DFQ35115646-7A7627B2-6962-4B3F-A5D5-762CC8F98F89Q35641431-CDF14689-13E0-4C98-87F2-8C95FFE21DAAQ36312170-DBE4B716-CD26-4235-807A-263C6056164CQ36481634-A84CA60A-0C48-4401-960A-EB1B8EC6D03AQ37164637-C2A0CDD1-D9A7-4D57-94AE-C94A8330D7F5Q37257349-6EC1898A-FAD6-45E4-A3A9-59470DEF6D46Q37426219-0E59085D-C56C-4AEA-9F57-4169F4ECAF86Q37462102-CD810D07-7542-46CF-85DB-61832C7CCF28Q37528882-4528B7BF-FC8A-48C7-8EB4-55A7F900D0CBQ38027954-AE910CF4-34E2-421C-BC14-A22BBD66281EQ39338533-2B2D1315-ED38-456D-8BE7-CAF4A4230F9BQ39926370-CFAA3D05-6DEC-451C-B68F-0E22F5C1129AQ39932759-2E82FBF4-E5D4-4146-9A7A-A068A56B377DQ40021164-844C57F2-338B-41D3-B8F8-F5C03996E339Q40059698-25926258-A6ED-4986-983C-4B54CC93F002Q40064663-21AF79B4-79E5-4EE4-AD84-70B6641C0452Q41035560-D64FCD3C-F386-4769-BFE6-5D5D41B401D5Q41253282-70416B44-9438-43A3-9F9B-81251A882EB3Q41918717-AE25FA8F-958C-4C6B-80FA-4BF501CA536FQ47108460-0F724ACA-7179-4287-9237-CAF8B9BE32F5
P2860
Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Analysis of novel human papill ...... W12 cervical epithelial cells
@ast
Analysis of novel human papill ...... W12 cervical epithelial cells
@en
type
label
Analysis of novel human papill ...... W12 cervical epithelial cells
@ast
Analysis of novel human papill ...... W12 cervical epithelial cells
@en
prefLabel
Analysis of novel human papill ...... W12 cervical epithelial cells
@ast
Analysis of novel human papill ...... W12 cervical epithelial cells
@en
P2093
P2860
P1433
P1476
Analysis of novel human papill ...... W12 cervical epithelial cells
@en
P2093
Boolang Ahamet
Sarah Mole
Sheila V Graham
Steven G Milligan
Thanaporn Veerapraditsin
P2860
P304
P356
10.1016/J.VIROL.2006.10.012
P407
P577
2006-11-13T00:00:00Z